Secukinumab in Active Rheumatoid Arthritis after Anti-TNFα Therapy: A Randomized, Double-Blind Placebo-Controlled Phase 3 Study

被引：0
|
作者：
Hasan Tahir
Atul Deodhar
Mark Genovese
Tsutomu Takeuchi
Jacob Aelion
Filip Van den Bosch
Sibylle Haemmerle
Hanno B. Richards
机构：
[1] Barts Health NHS Trust,
[2] Oregon Health and Science University,undefined
[3] Stanford University,undefined
[4] Keio University School of Medicine,undefined
[5] West Tennessee Research Institute,undefined
[6] Ghent University Hospital,undefined
[7] Novartis Pharma AG,undefined
来源：
Rheumatology and Therapy | 2017年 / 4卷
关键词：
ACR; Autoimmune; Biologic; Clinical trial; HAQ-DI; IL-17A; Randomized; Rheumatoid arthritis; Secukinumab; vdH-mTSS;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：475 / 488
页数：13
相关论文
共 50 条
  • [21] LACK OF EFFECT OF SECUKINUMAB TREATMENT ON THE LIPID PROFILE IN PATIENTS WITH RHEUMATOID ARTHRITIS: RESULTS FROM A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE II STUDY
    Durez, P.
    Genovese, M.
    Kellner, H.
    Codding, C.
    Ligozio, G.
    Richards, H.
    Escrig, C.
    Mpofu, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 194 - 195
  • [22] The Efficacy and Safety of Piclidenoson vs Methotrexate in Early Rheumatoid Arthritis: Phase 3 Randomized, Double-blind, Placebo-controlled Study
    Reitblat, Tatiana
    Gurman-Balbir, Alexandra
    Harpaz, Zivit
    Farbstein, Motti
    Silverman, Michael
    Kerns, William
    Fishman, Pnina
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3564 - 3566
  • [23] Vitamin D and immunomodulation in early rheumatoid arthritis: A randomized double-blind placebo-controlled study
    Buondonno, Ilaria
    Rovera, Guido
    Sassi, Francesca
    Rigoni, Micol Maria
    Lomater, Claudia
    Parisi, Simone
    Pellerito, Raffaele
    Isaia, Giovanni Carlo
    D'Amelio, Patrizia
    PLOS ONE, 2017, 12 (06):
  • [24] SAFETY AND EFFICACY OF SBI-087 IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS IN A PHASE 2 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Damjanov, N.
    Tlustochowicz, M.
    Aelion, J.
    Dimic, A.
    Greenwald, M.
    Diehl, A.
    Bhattacharya, I.
    Menon, S.
    Gourley, I.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 60 - 61
  • [25] Apremilast in Patients With Active Rheumatoid Arthritis: A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study
    Genovese, Mark C.
    Jarosova, Katerina
    Cieslak, Dorota
    Alper, Jeffrey
    Kivitz, Alan
    Hough, Douglas R.
    Maes, Peter
    Pineda, Lilia
    Chen, Mindy
    Zaidi, Farrukh
    ARTHRITIS & RHEUMATOLOGY, 2015, 67 (07) : 1703 - 1710
  • [26] Vunakizumab in Patients with Active Psoriatic Arthritis: A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 2 Study
    Zou, Hejian
    Wan, Weiguo
    Xue, Yu
    Sun, Lingyun
    Zhang, Ning
    Chen, Haiying
    Shi, Xiaofei
    Liu, Shengyun
    Chen, Lin
    Ma, Xinmei
    Wei, Hua
    Jiang, Zhenyu
    Li, Xiaomei
    Fan, Hongtao
    Li, Hongbin
    Li, Jingyang
    Wu, Rui
    Shi, Guixiu
    Zhu, Jing
    Kong, Xiaodan
    Lu, Yuewu
    Cui, Xiaojing
    Zheng, Qianning
    Bai, Xiaoyan
    Dong, Guangchao
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 5240 - 5242
  • [27] Secukinumab Provides Sustained Improvements in the Signs and Symptoms of Active Psoriatic Arthritis in Anti-TNF-Naive Patients and Those Previously Exposed to Anti-TNF Therapy: 52-Week Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial with Subcutaneous Dosing
    Kavanaugh, Arthur
    McInnes, Iain B.
    Mease, Philip J.
    Hall, Stephan
    Chinoy, Hector
    Kivitz, Alan J.
    Patekar, Manmath
    Wang, Zailong
    Mpofu, Shephard
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [28] TREATMENT OF ACTIVE RHEUMATOID-ARTHRITIS WITH SLOW INTRAVENOUS INJECTIONS OF THYMOPENTIN - A DOUBLE-BLIND PLACEBO-CONTROLLED RANDOMIZED STUDY
    MALAISE, MG
    FRANCHIMONT, P
    BACHANDERSEN, R
    GERBER, H
    STOCKER, H
    HAUWAERT, C
    DANNESKIOLDSAMSOE, B
    GROSS, D
    GERSCHPACHER, H
    BOLLA, K
    LANCET, 1985, 1 (8433): : 832 - 836
  • [29] Immunotherapy of acute rheumatoid arthritis (Double-blind, placebo-controlled study using Anti-IFN-γ and Anti-TNF-α antibodies).
    Loukina, G
    Sigidin, Y
    Pushkova, O
    Skurkovich, B
    Skurkovich, S
    CLINICAL IMMUNOLOGY, 2002, 103 (03) : S106 - S106
  • [30] Efficacy of ixekizumab in patients with psoriatic arthritis: Results of a phase 3 randomized, double-blind, active- and placebo-controlled study
    Mease, Philip
    van der Heijde, Desiree
    Ritchlin, Christopher
    Cuchacovich, Rachel
    Shuler, Catherine
    Lin, Chen-Yen
    Vangerow, Harald
    Samanta, Suvajit
    Lee, Chin
    Gladman, Dafna
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2016, 74 (05) : AB248 - AB248
12345